vs
Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and Third Coast Bancshares, Inc. (TCBX). Click either name above to swap in a different company.
Third Coast Bancshares, Inc. is the larger business by last-quarter revenue ($57.7M vs $40.7M, roughly 1.4× PETMED EXPRESS INC). Third Coast Bancshares, Inc. runs the higher net margin — 28.4% vs -26.0%, a 54.3% gap on every dollar of revenue. Over the past eight quarters, Third Coast Bancshares, Inc.'s revenue compounded faster (17.5% CAGR vs -20.9%).
PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.
Third Coast Bancshares, Inc. is a regional financial holding company headquartered in the U.S. Gulf Coast region. It provides a full suite of commercial and retail banking services including deposit products, business and consumer loans, mortgage services, and wealth management solutions, serving local small and medium-sized enterprises, individual consumers, and community clients across Texas and surrounding areas.
PETS vs TCBX — Head-to-Head
Income Statement — Q3 FY2026 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $40.7M | $57.7M |
| Net Profit | $-10.6M | $16.4M |
| Gross Margin | 23.3% | — |
| Operating Margin | -25.7% | — |
| Net Margin | -26.0% | 28.4% |
| Revenue YoY | -23.3% | — |
| Net Profit YoY | -1392.6% | 20.5% |
| EPS (diluted) | $-0.50 | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $57.7M | ||
| Q4 25 | $40.7M | $56.5M | ||
| Q3 25 | $44.4M | $54.5M | ||
| Q2 25 | $51.2M | $52.0M | ||
| Q1 25 | $50.8M | $45.9M | ||
| Q4 24 | $52.0M | $46.3M | ||
| Q3 24 | $58.0M | $42.9M | ||
| Q2 24 | $66.2M | $41.7M |
| Q1 26 | — | $16.4M | ||
| Q4 25 | $-10.6M | $17.9M | ||
| Q3 25 | $-8.5M | $18.1M | ||
| Q2 25 | $-34.2M | $16.7M | ||
| Q1 25 | $-11.6M | $13.6M | ||
| Q4 24 | $-707.0K | $13.7M | ||
| Q3 24 | $2.3M | $12.8M | ||
| Q2 24 | $3.8M | $10.8M |
| Q1 26 | — | — | ||
| Q4 25 | 23.3% | — | ||
| Q3 25 | 28.0% | — | ||
| Q2 25 | 28.1% | — | ||
| Q1 25 | 29.9% | — | ||
| Q4 24 | 31.0% | — | ||
| Q3 24 | 32.3% | — | ||
| Q2 24 | 28.8% | — |
| Q1 26 | — | — | ||
| Q4 25 | -25.7% | 38.1% | ||
| Q3 25 | -18.9% | 41.9% | ||
| Q2 25 | -66.7% | 40.5% | ||
| Q1 25 | -11.9% | 37.8% | ||
| Q4 24 | -0.9% | 38.7% | ||
| Q3 24 | 1.0% | 37.9% | ||
| Q2 24 | 6.6% | 34.1% |
| Q1 26 | — | 28.4% | ||
| Q4 25 | -26.0% | 31.7% | ||
| Q3 25 | -19.2% | 33.1% | ||
| Q2 25 | -66.7% | 32.2% | ||
| Q1 25 | -22.9% | 29.6% | ||
| Q4 24 | -1.4% | 29.7% | ||
| Q3 24 | 4.0% | 29.8% | ||
| Q2 24 | 5.7% | 25.9% |
| Q1 26 | — | $0.88 | ||
| Q4 25 | $-0.50 | $1.02 | ||
| Q3 25 | $-0.41 | $1.03 | ||
| Q2 25 | $-1.65 | $0.96 | ||
| Q1 25 | $-0.56 | $0.78 | ||
| Q4 24 | $-0.03 | $0.80 | ||
| Q3 24 | $0.11 | $0.74 | ||
| Q2 24 | $0.18 | $0.63 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.9M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $32.8M | $650.5M |
| Total Assets | $88.0M | $6.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $26.9M | $175.2M | ||
| Q3 25 | $36.1M | $116.4M | ||
| Q2 25 | $41.1M | $113.1M | ||
| Q1 25 | $54.7M | $219.0M | ||
| Q4 24 | $50.1M | $371.2M | ||
| Q3 24 | $52.0M | $258.2M | ||
| Q2 24 | $46.0M | $241.8M |
| Q1 26 | — | $650.5M | ||
| Q4 25 | $32.8M | $531.0M | ||
| Q3 25 | $43.1M | $513.8M | ||
| Q2 25 | $51.5M | $496.1M | ||
| Q1 25 | $85.1M | $479.8M | ||
| Q4 24 | $96.2M | $460.7M | ||
| Q3 24 | $96.4M | $450.5M | ||
| Q2 24 | $93.5M | $435.0M |
| Q1 26 | — | $6.6B | ||
| Q4 25 | $88.0M | $5.3B | ||
| Q3 25 | $100.3M | $5.1B | ||
| Q2 25 | $109.8M | $4.9B | ||
| Q1 25 | $148.7M | $4.9B | ||
| Q4 24 | $144.8M | $4.9B | ||
| Q3 24 | $146.0M | $4.6B | ||
| Q2 24 | $152.7M | $4.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-9.2M | — |
| Free Cash FlowOCF − Capex | $-9.2M | — |
| FCF MarginFCF / Revenue | -22.7% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-23.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-9.2M | $50.8M | ||
| Q3 25 | $-2.2M | $20.7M | ||
| Q2 25 | $-12.3M | $13.9M | ||
| Q1 25 | $7.0M | $10.5M | ||
| Q4 24 | $-1.2M | $35.1M | ||
| Q3 24 | $7.4M | $22.0M | ||
| Q2 24 | $-8.5M | $7.3M |
| Q1 26 | — | — | ||
| Q4 25 | $-9.2M | — | ||
| Q3 25 | $-4.8M | — | ||
| Q2 25 | $-13.6M | — | ||
| Q1 25 | $4.6M | — | ||
| Q4 24 | $-1.9M | $33.4M | ||
| Q3 24 | $6.1M | — | ||
| Q2 24 | $-9.2M | — |
| Q1 26 | — | — | ||
| Q4 25 | -22.7% | — | ||
| Q3 25 | -10.8% | — | ||
| Q2 25 | -26.5% | — | ||
| Q1 25 | 9.1% | — | ||
| Q4 24 | -3.7% | 72.1% | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | -13.9% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 1.5% | 3.8% | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.0% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.84× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | 2.56× | ||
| Q3 24 | 3.18× | 1.72× | ||
| Q2 24 | -2.27× | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PETS
| Reorder | $34.0M | 84% |
| New Order | $5.0M | 12% |
| Membership Fees | $1.6M | 4% |
TCBX
| Net Interest Income | $53.6M | 93% |
| Noninterest Income | $4.0M | 7% |